Uncovering the Human Secretome
揭开人类分泌蛋白组的面纱
基本信息
- 批准号:10223179
- 负责人:
- 金额:$ 118.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAmino AcidsBase PairingBiologicalBiological Response Modifier TherapyBiologyCodeCommunitiesComputer HardwareComputer softwareCustomDataDiseaseEmbryonic DevelopmentEndocrineGenerationsGenesGenetic DatabasesGenomeGoalsHormonesHumanHuman GenomeLibrariesLightMacacaMachine LearningMass Spectrum AnalysisMathematicsMedicineMethodsNoiseNuclearPan GenusParacrine CommunicationPeptidesPharmaceutical PreparationsPhysiological ProcessesProcessProteinsProteomicsRare DiseasesResearchSourceSpeedTechnologyTherapeuticTimeTissuesWorkYeastsbasedark matterdrug developmentflygenetic associationgenome annotationimprovedinterdisciplinary approachmitochondrial genomemultidisciplinarynovelpeptide hormoneprototyperesearch and developmentscreeningterabyte
项目摘要
PROJECT SUMMARY / ABSTRACT
Peptide hormones regulate embryonic development and most physiological processes by acting as endocrine
or paracrine signals. They are also a rich source of relatively safe medicines to treat both common and rare
diseases. Yet finding peptide-coding genes below ~300 base pairs is inherently difficult because they lie within
the noise of the genome. Recent multidisciplinary, proteophylogenomic studies in lower species, such as yeast
and flies, have uncovered hundreds of new small protein-coding genes called “smORFs”. In humans, recent
work on the mitochondrial genome has also uncovered dozens of small peptide hormone genes called MDPs.
Based on these and other studies, it is estimated that about 5% of proteins in the human nuclear genome have
not yet been discovered, particularly those that encode small peptides below 100 amino acids. It is a well
documented but rarely challenged practice to discard large quantities of sequencing and proteomic data
because they do not match the annotated human genome. My overarching goal is to discover the human
“secretome” and make practical use of it to improve the human condition. Over the past few years, we have
developed a unique pipeline of technologies that combines breakthroughs in math, computer hardware and
software, proteomics, mass spectrometry, and HTS screening, each of which has been optimized and
integrated. Our GeneFinder software modules, based on machine-learning, can process data 100 times faster
than traditional methods and rapidly validate small human genes using public and in-house generated
databases of genetic and proteomic data. Using the prototype version of the platform that finds conservation
between humans, chimp, and macaque, we have discovered thousands of putative peptide-coding genes and
validated hundreds of them. We aim to (1) further improve the algorithm to increase its speed and accuracy,
(2) improve the genome annotation for thousands of small novel genes, (3) determine their expression profiles
in normal and diseased tissues, (4) explore their genetic association with disease loci, and (5) screen the first
secretomic library to find hormones with novel biological and therapeutically relevant activities. The data, the
software package, and libraries will be made available to the research community. In doing so, we will shed
light on the dark matter of the human genome, the parts with the greatest therapeutic potential, thereby helping
to steer and accelerate the pace of research and drug development for generations to come.
项目总结/摘要
肽类激素通过内分泌调节胚胎发育和大多数生理过程
或旁分泌信号。它们也是治疗常见和罕见疾病的相对安全药物的丰富来源
疾病然而,找到低于300个碱基对的肽编码基因本质上是困难的,因为它们位于
基因组的噪音最近的多学科,蛋白系统基因组学研究在较低的物种,如酵母
和苍蝇,已经发现了数百个新的小蛋白质编码基因,称为“smORFs”。在人类中,最近
对线粒体基因组的研究还发现了几十种称为MDP的小肽激素基因。
基于这些和其他研究,估计人类核基因组中约5%的蛋白质具有
尚未发现,特别是那些编码低于100个氨基酸的小肽的。这是一个精心
丢弃大量测序和蛋白质组学数据的做法有文件记录,但很少受到挑战
因为它们与注释的人类基因组不匹配。我的首要目标是发现人类
“分泌物”,并实际利用它来改善人类的状况。在过去的几年里,我们
开发了一个独特的技术管道,结合了数学,计算机硬件和
软件、蛋白质组学、质谱和HTS筛选,每一项都经过优化,
整合我们基于机器学习的GeneBook软件模块可以以100倍的速度处理数据
与传统方法相比,使用公共和内部生成的
基因和蛋白质组数据库。使用平台的原型版本,
在人类、黑猩猩和猕猴之间,我们已经发现了数千个假定的肽编码基因,
验证了数百个。我们的目标是(1)进一步改进算法,以提高其速度和准确性,
(2)改进数千个新小基因的基因组注释,(3)确定其表达谱
在正常和患病组织中,(4)探索它们与疾病位点的遗传关联,以及(5)筛选第一个
分泌组文库,以寻找具有新的生物学和治疗相关活性的激素。数据,
将向研究界提供软件包和图书馆。这样做,我们将摆脱
人类基因组的暗物质,具有最大治疗潜力的部分,从而帮助
为子孙后代引导和加快研究和药物开发的步伐。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography.
- DOI:10.1002/jev2.12087
- 发表时间:2021-04
- 期刊:
- 影响因子:16
- 作者:Martínez-Greene JA;Hernández-Ortega K;Quiroz-Baez R;Resendis-Antonio O;Pichardo-Casas I;Sinclair DA;Budnik B;Hidalgo-Miranda A;Uribe-Querol E;Ramos-Godínez MDP;Martínez-Martínez E
- 通讯作者:Martínez-Martínez E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A. SINCLAIR其他文献
DAVID A. SINCLAIR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A. SINCLAIR', 18)}}的其他基金
Using cellular co-biosis and age programmable mice to derive a global interaction map of aging hallmarks
使用细胞共生和年龄可编程小鼠来得出衰老标志的全局相互作用图
- 批准号:
10721454 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Tagmentation-based Indexing for Methylation Sequencing as a novel method of high-throughput methylation clock measurement
基于标签的甲基化测序索引作为高通量甲基化时钟测量的新方法
- 批准号:
10273233 - 财政年份:2021
- 资助金额:
$ 118.65万 - 项目类别:
Nicotinamide Mononucleotide (NMN) as a Novel Therapeutic in the Treatment of Oral Mucositis
烟酰胺单核苷酸(NMN)作为治疗口腔粘膜炎的新疗法
- 批准号:
9770831 - 财政年份:2018
- 资助金额:
$ 118.65万 - 项目类别:
2009 Biology of Aging Gordon Research Conference
2009年衰老生物学戈登研究会议
- 批准号:
7613586 - 财政年份:2008
- 资助金额:
$ 118.65万 - 项目类别:
SIRT as a regulator of health and lifespan of mammals
SIRT 作为哺乳动物健康和寿命的调节剂
- 批准号:
7383794 - 财政年份:2007
- 资助金额:
$ 118.65万 - 项目类别:
SIRT as a regulator of health and lifespan of mammals
SIRT 作为哺乳动物健康和寿命的调节剂
- 批准号:
8048190 - 财政年份:2007
- 资助金额:
$ 118.65万 - 项目类别:
SIRT as a regulator of health and lifespan of mammals
SIRT 作为哺乳动物健康和寿命的调节剂
- 批准号:
7589667 - 财政年份:2007
- 资助金额:
$ 118.65万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 118.65万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 118.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:














{{item.name}}会员




